Improved growth during the first year of monthly intravenous pamidronate therapy in prepubertal patients with osteogenesis imperfecta

被引：0
|
作者：
Heino, Terhi J. [1 ,2 ,3 ]
Astrom, Eva [1 ,2 ]
Savendahl, Lars [1 ,2 ]
Soderhall, Stefan [1 ,2 ]
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden
[2] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden
[3] Univ Turku, Orthopaed Res Unit, Turku, Finland
来源：
HORMONE RESEARCH | 2009年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [41] Growth responses during the first year of growth hormone therapy: evaluation of height velocity targets
    Paul Saenger
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 258 - 259
  • [42] Growth responses during the first year of growth hormone therapy: evaluation of height velocity targets
    Saenger, P.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (05): : 258 - 259
  • [43] Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: A prospective controlled one-year study comparing a single infusion, a 3-monthly therapy and calcium alone.
    Boutsen, Y
    Jamart, J
    Esselinckx, W
    Devogelaer, JP
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S383 - S383
  • [44] Compliance with CPAP therapy in patients with obstructive sleep apnoea during the first year of treatment
    Kusk, Kathrine Hoffmann
    Boll, Birgitte
    Sorensen, Rikke Toftelund
    Jorgensen, Helle Mork
    Laugesen, Britt
    NORDISK SYGEPLEJEFORSKNING-NORDIC NURSING RESEARCH, 2022, 12 (01):
  • [45] Prevention of glucocorticoid-induced osteoporosis (GC-OP) with intravenous pamidronate and calcium: A prospective controlled one-year study comparing a single infusion, a 3-monthly therapy and calcium alone
    Boutsen, Y
    Jamart, J
    Esselinckx, W
    Devogelaer, JP
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S13 - S14
  • [46] Poor growth response during the first year of growth hormone treatment in short prepubertal children with growth hormone deficiency and born small for gestational age: a comparison of different criteria
    Straetemans, Saartje
    Thomas, Muriel
    Craen, Margarita
    Rooman, Raoul
    De Schepper, Jean
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2018,
  • [47] Insulin Sensitivity Modulates the Growth Response during the First Year of High-Dose Growth Hormone Treatment in Short Prepubertal Children Born Small for Gestational Age
    Gies, Inge
    Thomas, Muriel
    Tenoutasse, Sylvie
    De Waele, Kathleen
    Lebrethon, Marie-Christine
    Beckers, Dominique
    Francois, Inge
    Maes, Marc
    Rooman, Raoul
    De Beaufort, Carine
    Massa, Guy
    De Schepper, Jean
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 78 (01): : 24 - 30
  • [48] Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy
    Thorner, M
    Rochiccioli, P
    Colle, M
    Lanes, R
    Grunt, J
    Galazka, A
    Landy, H
    Eengrand, P
    Shah, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03): : 1189 - 1196
  • [49] THYROID FUNCTION DURING THE FIRST YEAR OF RECOMBINANT HUMAN GROWTH HORMONE THERAPY IN SHORT STATURE CHILDREN
    Capraru, Oana-Maria
    Pascanu, Ionela M.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2014, 118 (02): : 307 - 314
  • [50] Dialysis modality does not influence the quality of life of patients during the first year of therapy.
    Jofre, R
    Fort, J
    Sanz-Guajardo, D
    Vazquez, I
    Lopez-Gomez, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 398A - 399A
12345